Skip to content
All Sections
Subscribe Now
67°F
Monday, September 2nd 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
67°F
Monday, September 2nd 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
High School Football
Greek Festival info ð¬ð·
Latest on RPV landslide
Shooting suspect arrested
Hot Dog on a Stick #2 closing
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Equillium, Inc.
< Previous
1
2
Next >
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
August 28, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
August 06, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
July 18, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Participate in Upcoming Investor Conferences
July 02, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to be included in the Russell Microcap® Index
June 12, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
May 14, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 07, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
April 01, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
March 25, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
March 22, 2024
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
December 21, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
November 13, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
November 08, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
November 06, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Host Analyst & Investor Day
October 03, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the JonesTrading 2023 Healthcare Summit
October 02, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
September 20, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference
August 30, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
August 09, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces $7.5 Million Share Repurchase Program
August 02, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences
June 01, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 15, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
May 11, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation
April 24, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates
March 23, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference
March 22, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR
February 17, 2023
From
Equillium, Inc.
Via
Business Wire
Tickers
EQ
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close